China (Mainland)
Premiumsupplier
Octreotide Acetate CAS NO.83150-76-9
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T
- Product Details
Keywords
- Acetato de octreotida,octreotida,Octreotide
- Acétate d'octréotide,Октреотид,octréotide
- Acetato de octreotida,Октреотид ацетат
Quick Details
- ProName: Octreotide Acetate
- CasNo: 83150-76-9
- Molecular Formula: C49H66N10O10S2.2(C2H4O2)
- Appearance: white to off white
- Application: This medicine is given to control symp...
- DeliveryTime: Ready in Stock
- PackAge: Aluminum Foil Bag
- Port: HK/Shenzhen
- ProductionCapacity: 500 Kilogram/Year
- Purity: ≥98%
- Storage: 2-8 degree
- Transportation: Cold chain and cool storage delivery f...
- LimitNum: 1 Gram
Superiority
The first listed company in peptides industry, mature process, stable and advaced technology,API capacity reaches to 500kg with 3 main factory sites.
Details
What's Octreotide Acetate
Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.
Applications
NREMS and SWA were normal after 1 µgoctreotide. REMS, however, enhanced significantly during the light period. The increases in REMS started 2-3 h postinjection and persisted during the rest of the day, although they were very small when the individual hours were considered. In response to 10 µg octreotide, NREMS was significantly suppressed in hour 1 postinjection. Calculated for the 12-h light period, NREMS or SWA did not differ between the baseline and the octreotide days.how does it work
Octreotide is also used to treat acromegaly. Acromegaly is a rare hormonal disorder that affects adults in which there is an over production of growth hormone that leads to the abnormal growth of the hands, feet, or facial features. Octreotide significantly decreases the levels of growth hormone and IGF-I (somatomedin C) in patients with acromegaly.
